Financhill
Sell
28

CYCL Quote, Financials, Valuation and Earnings

Last price:
$0.0500
Seasonality move :
23.44%
Day range:
$0.0500 - $0.0500
52-week range:
$0.0003 - $0.1500
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
--
Avg. volume:
9.2K
1-year change:
11.11%
Market cap:
$2M
Revenue:
--
EPS (TTM):
--

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CYCL
Cycclone
-- -- -- -- --
CCAP
Crescent Capital BDC
$45.1M $0.53 85.64% -14.91% $17.33
DMYY
dMY Squared Technology Group
-- -- -- -- --
FHLT
Future Health ESG
-- -- -- -- --
GRAF
Graf Global
-- -- -- -- --
LEGT
Legato Merger Corp III
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CYCL
Cycclone
$0.0500 -- $2M -- $0.00 0% --
CCAP
Crescent Capital BDC
$14.48 $17.33 $536.7M 10.81x $0.05 13.47% 8.87x
DMYY
dMY Squared Technology Group
$13.15 -- $51.5M 59.33x $0.00 0% --
FHLT
Future Health ESG
$10.96 -- $65.1M -- $0.00 0% --
GRAF
Graf Global
$10.46 -- $300.8M 39.44x $0.00 0% --
LEGT
Legato Merger Corp III
$10.68 -- $275.5M 28.11x $0.00 0% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CYCL
Cycclone
-- 2.341 -- --
CCAP
Crescent Capital BDC
55.39% 0.707 142.31% 0.62x
DMYY
dMY Squared Technology Group
-- 0.234 -- --
FHLT
Future Health ESG
-- 0.000 -- --
GRAF
Graf Global
-- 0.000 -- --
LEGT
Legato Merger Corp III
-- -0.036 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CYCL
Cycclone
-- -- -- -- -- --
CCAP
Crescent Capital BDC
-- -- 3.07% 6.66% 254.33% -$15.1M
DMYY
dMY Squared Technology Group
-- -$492.2K -- -- -- -$773.6K
FHLT
Future Health ESG
-- -- -- -- -- --
GRAF
Graf Global
-- -$273.2K -- -- -- -$119.5K
LEGT
Legato Merger Corp III
-- -$308.6K -- -- -- -$248.8K

Cycclone vs. Competitors

  • Which has Higher Returns CYCL or CCAP?

    Crescent Capital BDC has a net margin of -- compared to Cycclone's net margin of 54.76%. Cycclone's return on equity of -- beat Crescent Capital BDC's return on equity of 6.66%.

    Company Gross Margin Earnings Per Share Invested Capital
    CYCL
    Cycclone
    -- -- --
    CCAP
    Crescent Capital BDC
    -- $0.11 $1.6B
  • What do Analysts Say About CYCL or CCAP?

    Cycclone has a consensus price target of --, signalling downside risk potential of --. On the other hand Crescent Capital BDC has an analysts' consensus of $17.33 which suggests that it could grow by 19.71%. Given that Crescent Capital BDC has higher upside potential than Cycclone, analysts believe Crescent Capital BDC is more attractive than Cycclone.

    Company Buy Ratings Hold Ratings Sell Ratings
    CYCL
    Cycclone
    0 0 0
    CCAP
    Crescent Capital BDC
    3 2 0
  • Is CYCL or CCAP More Risky?

    Cycclone has a beta of 2.155, which suggesting that the stock is 115.494% more volatile than S&P 500. In comparison Crescent Capital BDC has a beta of 0.552, suggesting its less volatile than the S&P 500 by 44.821%.

  • Which is a Better Dividend Stock CYCL or CCAP?

    Cycclone has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Crescent Capital BDC offers a yield of 13.47% to investors and pays a quarterly dividend of $0.05 per share. Cycclone pays -- of its earnings as a dividend. Crescent Capital BDC pays out 102.15% of its earnings as a dividend.

  • Which has Better Financial Ratios CYCL or CCAP?

    Cycclone quarterly revenues are --, which are smaller than Crescent Capital BDC quarterly revenues of $7.1M. Cycclone's net income of -- is lower than Crescent Capital BDC's net income of $3.9M. Notably, Cycclone's price-to-earnings ratio is -- while Crescent Capital BDC's PE ratio is 10.81x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cycclone is -- versus 8.87x for Crescent Capital BDC. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CYCL
    Cycclone
    -- -- -- --
    CCAP
    Crescent Capital BDC
    8.87x 10.81x $7.1M $3.9M
  • Which has Higher Returns CYCL or DMYY?

    dMY Squared Technology Group has a net margin of -- compared to Cycclone's net margin of --. Cycclone's return on equity of -- beat dMY Squared Technology Group's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CYCL
    Cycclone
    -- -- --
    DMYY
    dMY Squared Technology Group
    -- -$1.16 --
  • What do Analysts Say About CYCL or DMYY?

    Cycclone has a consensus price target of --, signalling downside risk potential of --. On the other hand dMY Squared Technology Group has an analysts' consensus of -- which suggests that it could fall by --. Given that Cycclone has higher upside potential than dMY Squared Technology Group, analysts believe Cycclone is more attractive than dMY Squared Technology Group.

    Company Buy Ratings Hold Ratings Sell Ratings
    CYCL
    Cycclone
    0 0 0
    DMYY
    dMY Squared Technology Group
    0 0 0
  • Is CYCL or DMYY More Risky?

    Cycclone has a beta of 2.155, which suggesting that the stock is 115.494% more volatile than S&P 500. In comparison dMY Squared Technology Group has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock CYCL or DMYY?

    Cycclone has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. dMY Squared Technology Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cycclone pays -- of its earnings as a dividend. dMY Squared Technology Group pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CYCL or DMYY?

    Cycclone quarterly revenues are --, which are smaller than dMY Squared Technology Group quarterly revenues of --. Cycclone's net income of -- is lower than dMY Squared Technology Group's net income of -$4.6M. Notably, Cycclone's price-to-earnings ratio is -- while dMY Squared Technology Group's PE ratio is 59.33x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cycclone is -- versus -- for dMY Squared Technology Group. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CYCL
    Cycclone
    -- -- -- --
    DMYY
    dMY Squared Technology Group
    -- 59.33x -- -$4.6M
  • Which has Higher Returns CYCL or FHLT?

    Future Health ESG has a net margin of -- compared to Cycclone's net margin of --. Cycclone's return on equity of -- beat Future Health ESG's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CYCL
    Cycclone
    -- -- --
    FHLT
    Future Health ESG
    -- -- --
  • What do Analysts Say About CYCL or FHLT?

    Cycclone has a consensus price target of --, signalling downside risk potential of --. On the other hand Future Health ESG has an analysts' consensus of -- which suggests that it could fall by --. Given that Cycclone has higher upside potential than Future Health ESG, analysts believe Cycclone is more attractive than Future Health ESG.

    Company Buy Ratings Hold Ratings Sell Ratings
    CYCL
    Cycclone
    0 0 0
    FHLT
    Future Health ESG
    0 0 0
  • Is CYCL or FHLT More Risky?

    Cycclone has a beta of 2.155, which suggesting that the stock is 115.494% more volatile than S&P 500. In comparison Future Health ESG has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock CYCL or FHLT?

    Cycclone has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Future Health ESG offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cycclone pays -- of its earnings as a dividend. Future Health ESG pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CYCL or FHLT?

    Cycclone quarterly revenues are --, which are smaller than Future Health ESG quarterly revenues of --. Cycclone's net income of -- is lower than Future Health ESG's net income of --. Notably, Cycclone's price-to-earnings ratio is -- while Future Health ESG's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cycclone is -- versus -- for Future Health ESG. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CYCL
    Cycclone
    -- -- -- --
    FHLT
    Future Health ESG
    -- -- -- --
  • Which has Higher Returns CYCL or GRAF?

    Graf Global has a net margin of -- compared to Cycclone's net margin of --. Cycclone's return on equity of -- beat Graf Global's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CYCL
    Cycclone
    -- -- --
    GRAF
    Graf Global
    -- $0.08 --
  • What do Analysts Say About CYCL or GRAF?

    Cycclone has a consensus price target of --, signalling downside risk potential of --. On the other hand Graf Global has an analysts' consensus of -- which suggests that it could fall by --. Given that Cycclone has higher upside potential than Graf Global, analysts believe Cycclone is more attractive than Graf Global.

    Company Buy Ratings Hold Ratings Sell Ratings
    CYCL
    Cycclone
    0 0 0
    GRAF
    Graf Global
    0 0 0
  • Is CYCL or GRAF More Risky?

    Cycclone has a beta of 2.155, which suggesting that the stock is 115.494% more volatile than S&P 500. In comparison Graf Global has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock CYCL or GRAF?

    Cycclone has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Graf Global offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cycclone pays -- of its earnings as a dividend. Graf Global pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CYCL or GRAF?

    Cycclone quarterly revenues are --, which are smaller than Graf Global quarterly revenues of --. Cycclone's net income of -- is lower than Graf Global's net income of $2.2M. Notably, Cycclone's price-to-earnings ratio is -- while Graf Global's PE ratio is 39.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cycclone is -- versus -- for Graf Global. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CYCL
    Cycclone
    -- -- -- --
    GRAF
    Graf Global
    -- 39.44x -- $2.2M
  • Which has Higher Returns CYCL or LEGT?

    Legato Merger Corp III has a net margin of -- compared to Cycclone's net margin of --. Cycclone's return on equity of -- beat Legato Merger Corp III's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CYCL
    Cycclone
    -- -- --
    LEGT
    Legato Merger Corp III
    -- $0.08 --
  • What do Analysts Say About CYCL or LEGT?

    Cycclone has a consensus price target of --, signalling downside risk potential of --. On the other hand Legato Merger Corp III has an analysts' consensus of -- which suggests that it could fall by --. Given that Cycclone has higher upside potential than Legato Merger Corp III, analysts believe Cycclone is more attractive than Legato Merger Corp III.

    Company Buy Ratings Hold Ratings Sell Ratings
    CYCL
    Cycclone
    0 0 0
    LEGT
    Legato Merger Corp III
    0 0 0
  • Is CYCL or LEGT More Risky?

    Cycclone has a beta of 2.155, which suggesting that the stock is 115.494% more volatile than S&P 500. In comparison Legato Merger Corp III has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock CYCL or LEGT?

    Cycclone has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Legato Merger Corp III offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cycclone pays -- of its earnings as a dividend. Legato Merger Corp III pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CYCL or LEGT?

    Cycclone quarterly revenues are --, which are smaller than Legato Merger Corp III quarterly revenues of --. Cycclone's net income of -- is lower than Legato Merger Corp III's net income of $1.9M. Notably, Cycclone's price-to-earnings ratio is -- while Legato Merger Corp III's PE ratio is 28.11x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cycclone is -- versus -- for Legato Merger Corp III. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CYCL
    Cycclone
    -- -- -- --
    LEGT
    Legato Merger Corp III
    -- 28.11x -- $1.9M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Google Stock Double by 2030?
Will Google Stock Double by 2030?

If you bought Alphabet (NASDAQ: GOOGL) when Gmail launched in…

Why Did David Tepper Sell NVIDIA Stock?
Why Did David Tepper Sell NVIDIA Stock?

In Q1, billionaire David Tepper of Appaloosa Management sold nearly…

Why Is Planet Labs Stock Up Today?
Why Is Planet Labs Stock Up Today?

Planet Labs (NYSE: PL) opened Friday trading with an unmistakable…

Stock Ideas

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 54x

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 42x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
49
NKE alert for Jun 28

Nike [NKE] is up 15.29% over the past day.

Buy
81
KTOS alert for Jun 28

Kratos Defense & Security Solutions [KTOS] is up 10.89% over the past day.

Sell
44
GDXU alert for Jun 28

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 10.89% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock